Loading
Synthio Labs
Synthio Labs is a clinical-grade, multimodal Agentic AI platform founded in 2024 and based in San Francisco. The company aims to revolutionize how life sciences organizations interact with healthcare professionals, patients, and field teams through compliant voice and text communications. Their mission is to create the world's first AI Medical Expert for Pharma Go-To-Market teams, serving as a vital intelligence layer for modern life sciences engagement. The company offers a range of specialized AI agents tailored for specific pharmaceutical workflows. Key products include Jarvis, a voice AI copilot for pharma field teams; Ather, a multimodal AI engine for engaging healthcare professionals and patients; and Simulation Studio, which creates digital twins for strategy testing. Synthio Labs focuses on compliant engagement, automating medical information requests, and providing omnichannel access for 24/7 support. With backing from notable investors and a growing team, Synthio Labs is positioned to make a significant impact in the pharmaceutical and biotech sectors.
Funding
Every round, secondary, debt facility or acquisition involving Synthio Labs that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—